Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Biomedicines|July 27, 2022
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate CancerPengfei Xu, Logan J Wasielewski, Joy C Yang, et al.
Cancer Research|January 2, 2009
Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancerJoy C Yang, Joon-ha Ok, J Erik Busby, et al.
Cancer Research|February 5, 2015
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate CancerChengfei Liu, Wei Lou, Yezi Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Interleukin-6 regulates androgen synthesis in prostate cancer cellsJae Yeon Chun, Nagalakshmi Nadiminty, Smitha Dutt, et al.
Molecular Cancer Therapeutics|July 26, 2019
GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 ExpressionVito Cucchiara, Joy C Yang, Chengfei Liu, et al.
Molecular Cancer Therapeutics|June 13, 2018
Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate CancerAlan P Lombard, Liangren Liu, Vito Cucchiara, et al.
Journal for Immunotherapy of Cancer|May 5, 2023
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironmentPengfei Xu, Joy C Yang, Bo Chen, et al.
Molecular Cancer Therapeutics|May 21, 2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate CancerJinge Zhao, Shu Ning, Wei Lou, et al.
Molecular Cancer Therapeutics|May 14, 2017
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate CancerChengfei Liu, Cameron M Armstrong, Wei Lou, et al.
Molecular Cancer Therapeutics|July 17, 2019
AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate CancerChengfei Liu, Joy C Yang, Cameron M Armstrong, et al.
Pageof 4